azomycin has been researched along with Carcinoma, Transitional Cell in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (75.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Daley, FM; Hoskin, PJ; Saunders, MI; Sibtain, A; Wilson, GD | 1 |
Abd El Baki, H; Abd El Moneim, H; Awwad, HK; El Merzabani, M; Farag, HI; Omar, S | 1 |
Forgione, H; Kramer, S; Mohiuddin, M; Phillips, T; Soberon, M | 1 |
Hampel, N; Persky, L | 1 |
4 other study(ies) available for azomycin and Carcinoma, Transitional Cell
Article | Year |
---|---|
The immunohistochemical assessment of hypoxia, vascularity and proliferation in bladder carcinoma.
Topics: Antigens, CD34; Biomarkers, Tumor; Carcinoma, Transitional Cell; Cell Hypoxia; Cell Proliferation; Cyclin A; Female; Humans; Immunohistochemistry; Ki-67 Antigen; Male; Neoplasm Staging; Neovascularization, Pathologic; Nitroimidazoles; Platelet Endothelial Cell Adhesion Molecule-1; Radiation-Sensitizing Agents; Staining and Labeling; Urinary Bladder Neoplasms | 2004 |
The topical use of misonidazole in bladder cancer.
Topics: Administration, Oral; Administration, Topical; Carcinoma, Squamous Cell; Carcinoma, Transitional Cell; Humans; Kinetics; Misonidazole; Mucous Membrane; Nitroimidazoles; Urinary Bladder; Urinary Bladder Neoplasms | 1983 |
Preliminary results of RTOG phase I/II study of misonidazole and radiation for bladder cancer.
Topics: Aged; Carcinoma, Transitional Cell; Drug Evaluation; Female; Humans; Intestinal Obstruction; Intestine, Small; Male; Middle Aged; Misonidazole; Nitroimidazoles; Radiotherapy; Radiotherapy Dosage; Urinary Bladder Neoplasms | 1982 |
Influence of misonidazole on the radiosensitivity of transplantable transitional cell bladder carcinoma in mice.
Topics: Animals; Carcinoma, Transitional Cell; Dose-Response Relationship, Radiation; Mice; Mice, Inbred C3H; Misonidazole; Neoplasm Transplantation; Neoplasms, Experimental; Nitroimidazoles; Prognosis; Radiation-Sensitizing Agents; Urinary Bladder Neoplasms | 1981 |